Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 1;32(5):634-641.
doi: 10.1158/1055-9965.EPI-22-0966.

Rural, Large Town, and Urban Differences in Optimal Subspecialty Follow-up and Survivorship Care Plan Documentation among Childhood Cancer Survivors

Affiliations

Rural, Large Town, and Urban Differences in Optimal Subspecialty Follow-up and Survivorship Care Plan Documentation among Childhood Cancer Survivors

David H Noyd et al. Cancer Epidemiol Biomarkers Prev. .

Abstract

Background: Children with cancer from rural and nonurban areas face unique challenges. Health equity for this population requires attention to geographic disparities in optimal survivorship-focused care.

Methods: The Oklahoma Childhood Cancer Survivor Cohort was based on all patients reported to the institutional cancer registry and ≤ 18 years old at diagnosis between January 1, 2005, and September 24, 2014. Suboptimal follow-up was defined as no completed oncology-related clinic visit five to 7 years after their initial diagnosis (survivors were 7-25 years old at end of the follow-up period). The primary predictor of interest was rurality.

Results: Ninety-four (21%) of the 449 eligible survivors received suboptimal follow-up. There were significant differences (P = 0.01) as 36% of survivors from large towns (n = 28/78) compared with 21% (n = 20/95) and 17% (n = 46/276) of survivors from small town/isolated rural and urban areas received suboptimal follow-up, respectively. Forty-five percent of adolescents at diagnosis were not seen in the clinic compared with 17% of non-adolescents (P < 0.01). An adjusted risk ratio of 2.2 (95% confidence interval, 1.5, 3.2) was observed for suboptimal follow-up among survivors from large towns, compared with survivors from urban areas. Seventy-three percent of survivors (n = 271/369) had a documented survivorship care plan with similar trends by rurality.

Conclusions: Survivors from large towns and those who were adolescents at the time of diagnosis were more likely to receive suboptimal follow-up care compared with survivors from urban areas and those diagnosed younger than thirteen.

Impact: Observed geographic disparities in survivorship care will inform interventions to promote equitable care for survivors from nonurban areas.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare no competing interests.

Figures

Figure 1.
Figure 1.
Oklahoma Childhood Cancer Survivor Cohort Construction.
Figure 2.
Figure 2.
Geographic distribution of optimal subspecialty follow-up 5–7 years after initial diagnosis

Similar articles

Cited by

References

    1. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. Jan 2014;14(1):61–70. doi:10.1038/nrc3634 - DOI - PMC - PubMed
    1. Armstrong GT, Chen Y, Yasui Y, et al. Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. New England Journal of Medicine. 2016;374(9):833–842. doi:10.1056/NEJMoa1510795 - DOI - PMC - PubMed
    1. Dixon SB. A decreasing cost of cure in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. Jan 2022;69(1):e29429. doi:10.1002/pbc.29429 - DOI - PubMed
    1. Gibson TM, Mostoufi-Moab S, Stratton KL, et al. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. Dec 2018;19(12):1590–1601. doi:10.1016/s1470-2045(18)30537-0 - DOI - PMC - PubMed
    1. Williams AM, Liu Q, Bhakta N, et al. Rethinking Success in Pediatric Oncology: Beyond 5-Year Survival. J Clin Oncol. Jul 10 2021;39(20):2227–2231. doi:10.1200/jco.20.03681 - DOI - PMC - PubMed

Publication types